BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30649790)

  • 21. Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
    Schaff LR; Yan D; Thyparambil S; Tian Y; Cecchi F; Rosenblum M; Reiner AS; Panageas KS; Hembrough T; Lin AL
    J Neurooncol; 2020 Jan; 146(1):163-170. PubMed ID: 31823165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
    Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
    Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit and outcome of using temozolomide-based chemoradiotherapy followed by temozolomide alone for glioblastoma in clinical practice.
    Salma S; Djan I; Bjelan M; Vulekovic P; Novakovic M; Vidovic V; Lucic M
    J BUON; 2017; 22(5):1233-1239. PubMed ID: 29135107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface GRP78 as a biomarker and target for suppressing glioma cells.
    Kang BR; Yang SH; Chung BR; Kim W; Kim Y
    Sci Rep; 2016 Oct; 6():34922. PubMed ID: 27713511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
    Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
    BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
    Younis SG; Khedr RA; El-Shorbagy SH
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
    Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
    Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
    Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
    Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
    Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
    World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
    Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
    Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
    Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
    Kesari S; Ram Z;
    CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis.
    Lu VM; Kerezoudis P; Brown DA; Burns TC; Quinones-Hinojosa A; Chaichana KL
    J Neurooncol; 2019 Jun; 143(2):177-185. PubMed ID: 30919157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
    Saito T; Muragaki Y; Maruyama T; Komori T; Nitta M; Tsuzuki S; Fukui A; Kawamata T
    Neurosurg Rev; 2020 Dec; 43(6):1583-1593. PubMed ID: 31705405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioblastoma management in the temozolomide era: have we improved outcome?
    Lwin Z; MacFadden D; Al-Zahrani A; Atenafu E; Miller BA; Sahgal A; Menard C; Laperriere N; Mason WP
    J Neurooncol; 2013 Nov; 115(2):303-10. PubMed ID: 23979682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
    Hunn MK; Bauer E; Wood CE; Gasser O; Dzhelali M; Ancelet LR; Mester B; Sharples KJ; Findlay MP; Hamilton DA; Hermans IF
    J Neurooncol; 2015 Jan; 121(2):319-29. PubMed ID: 25366363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.